New monoclonal antibody therapies can slow early cognitive decline in Alzheimer's patients, but referral delays of weeks prevent timely treatment initiation. AI triage agent will summarize patient information, flag missing details, and recommend priority routing while allowing clinicians to override recommendations.
Vanderbilt develops AI tool to speed Alzheimer's patient referrals and treatment
Alzheimer's patients experience weeks of treatment delays that accelerate cognitive decline, directly impacting disease progression and quality of life.